To include your compound in the COVID-19 Resource Center, submit it here.

EMA urges recall of MS drug Zinbryta

EMA recommended immediate suspension and recall of multiple sclerosis drug Zinbryta daclizumab from Biogen Inc.

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE